Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal Transplantation

Clinical Trial ID NCT01035593

PubWeight™ 1.59‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01035593

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Applying complement therapeutics to rare diseases. Clin Immunol 2015 0.87
2 Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective. Clin Exp Immunol 2015 0.75
Next 100